Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy
Top Cited Papers
- 1 October 2010
- journal article
- autobiography
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 16 (10), 1107-1111
- https://doi.org/10.1038/nm1010-1107
Abstract
No abstract availableKeywords
This publication has 56 references indexed in Scilit:
- Binding to the Extracellular Matrix and Proteolytic Processing: Two Key Mechanisms Regulating Vascular Endothelial Growth Factor ActionMolecular Biology of the Cell, 2010
- Age-Related Macular DegenerationThe New England Journal of Medicine, 2008
- Ranibizumab for Neovascular Age-Related Macular DegenerationThe New England Journal of Medicine, 2006
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNature Reviews Drug Discovery, 2004
- Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured fab in complex with antigenJournal of Molecular Biology, 1999
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factorBiochemical and Biophysical Research Communications, 1992
- Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cellsBiochemical and Biophysical Research Communications, 1989
- Tumor Angiogenesis: Therapeutic ImplicationsThe New England Journal of Medicine, 1971